Brief: Bolt Biotherapeutics Shares Open 30.5% Above IPO Price In Nasdaq Debut
Feb 5 (Reuters) -
* BOLT BIOTHERAPEUTICS SHARES OPEN AT $26.10 IN NASDAQ DEBUT VERSUS IPO
PRICE OF
$20.00/SHARE
Further company coverage: BOLT.O
((Reuters.Briefs@thomsonreuters.com;))